InvivoGen
Biotechnology ResearchCalifornia, United States51-200 Employees
InvivoGen operates in biotechnology research with a focus on cell culture engineering and innate immunity. The company develops and provides reagents produced through microbial fermentation, including bioactive molecules and a wide collection of pattern recognition receptor agonists, for life science researchers worldwide. Its research and development teams design, produce, and validate tools for studies in gene therapy, molecular immunology, and vaccination, and it offers reporter and knockout cell lines that reflect innate immune signaling pathways. Based in San Diego, California, InvivoGen maintains three regional headquarters in Toulouse, San Diego, and Hong Kong and supports customers through multilingual staff. Founded in 1977 by university researchers in Toulouse, France, the privately held company has expanded internationally with additional sites and global reach. A recent development noted in August 2024 is a partnership with Bioz, integrating Bioz's search and analytics platform with InvivoGen's catalog.